Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells.

Kim WJ, Shea AE, Kim JH, Daaka Y.

J Biol Chem. 2018 Oct 19;293(42):16518-16527. doi: 10.1074/jbc.RA118.003499. Epub 2018 Aug 30.

PMID:
30166343
2.

Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.

Li D, Tian G, Wang J, Zhao LY, Co O, Underill ZC, Mymryk JS, Claessens F, Dehm SM, Daaka Y, Liao D.

Prostate. 2018 Nov;78(15):1140-1156. doi: 10.1002/pros.23689. Epub 2018 Jul 15.

PMID:
30009471
3.

βArrestin2 Mediates Renal Cell Carcinoma Tumor Growth.

Masannat J, Purayil HT, Zhang Y, Russin M, Mahmud I, Kim W, Liao D, Daaka Y.

Sci Rep. 2018 Mar 20;8(1):4879. doi: 10.1038/s41598-018-23212-w.

4.

β-Arrestin1 mediates hMENA expression and ovarian cancer metastasis.

Purayil HT, Daaka Y.

Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):2856-2858. doi: 10.1073/pnas.1802643115. Epub 2018 Mar 7. No abstract available.

5.

Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis.

Zhang Y, Thayele Purayil H, Black JB, Fetto F, Lynch LD, Masannat JN, Daaka Y.

Cancer Lett. 2017 Apr 10;391:50-58. doi: 10.1016/j.canlet.2017.01.007. Epub 2017 Jan 17.

6.

Biased α-adrenergic receptor and βarrestin signaling in a cell culture model of benign prostatic hyperplasia.

Wang M, Daaka Y, Dey A.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):41-6. doi: 10.1016/j.bbrc.2016.02.002. Epub 2016 Feb 3.

PMID:
26850854
7.

Feedback regulation of G protein-coupled receptor signaling by GRKs and arrestins.

Black JB, Premont RT, Daaka Y.

Semin Cell Dev Biol. 2016 Feb;50:95-104. doi: 10.1016/j.semcdb.2015.12.015. Epub 2016 Jan 7. Review.

8.

The stress response neuropeptide CRF increases amyloid-β production by regulating γ-secretase activity.

Park HJ, Ran Y, Jung JI, Holmes O, Price AR, Smithson L, Ceballos-Diaz C, Han C, Wolfe MS, Daaka Y, Ryabinin AE, Kim SH, Hauger RL, Golde TE, Felsenstein KM.

EMBO J. 2015 Jun 12;34(12):1674-86. doi: 10.15252/embj.201488795. Epub 2015 May 11.

9.

Arrestin2 modulates androgen receptor activation.

Purayil HT, Zhang Y, Dey A, Gersey Z, Espana-Serrano L, Daaka Y.

Oncogene. 2015 Jun 11;34(24):3144-51. doi: 10.1038/onc.2014.252. Epub 2014 Aug 11.

PMID:
25109335
10.

Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium.

Saldaña Z, De la Cruz MA, Carrillo-Casas EM, Durán L, Zhang Y, Hernández-Castro R, Puente JL, Daaka Y, Girón JA.

PLoS One. 2014 Jul 18;9(7):e101200. doi: 10.1371/journal.pone.0101200. eCollection 2014.

11.

G protein-coupled receptor kinase GRK5 phosphorylates moesin and regulates metastasis in prostate cancer.

Chakraborty PK, Zhang Y, Coomes AS, Kim WJ, Stupay R, Lynch LD, Atkinson T, Kim JI, Nie Z, Daaka Y.

Cancer Res. 2014 Jul 1;74(13):3489-500. doi: 10.1158/0008-5472.CAN-13-2708. Epub 2014 Apr 22.

12.

βArrestin1 regulates the guanine nucleotide exchange factor RasGRF2 expression and the small GTPase Rac-mediated formation of membrane protrusion and cell motility.

Ma X, Espana-Serrano L, Kim WJ, Thayele Purayil H, Nie Z, Daaka Y.

J Biol Chem. 2014 May 9;289(19):13638-50. doi: 10.1074/jbc.M113.511360. Epub 2014 Apr 1.

13.

Maintenance of androgen receptor inactivation by S-nitrosylation.

Qin Y, Dey A, Purayil HT, Daaka Y.

Cancer Res. 2013 Nov 15;73(22):6690-9. doi: 10.1158/0008-5472.CAN-13-1042. Epub 2013 Oct 11.

14.

Protein s-nitrosylation measurement.

Qin Y, Dey A, Daaka Y.

Methods Enzymol. 2013;522:409-25. doi: 10.1016/B978-0-12-407865-9.00019-4. Review.

PMID:
23374195
15.

Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas.

Eruslanov E, Stoffs T, Kim WJ, Daurkin I, Gilbert SM, Su LM, Vieweg J, Daaka Y, Kusmartsev S.

Clin Cancer Res. 2013 Apr 1;19(7):1670-80. doi: 10.1158/1078-0432.CCR-12-2091. Epub 2013 Jan 30.

16.

Dynamin2 S-nitrosylation regulates adenovirus type 5 infection of epithelial cells.

Wang Z, Kim JI, Frilot N, Daaka Y.

J Gen Virol. 2012 Oct;93(Pt 10):2109-17. doi: 10.1099/vir.0.042713-0. Epub 2012 Jul 12.

17.

PGE2 promotes renal carcinoma cell invasion through activated RalA.

Li Z, Zhang Y, Kim WJ, Daaka Y.

Oncogene. 2013 Mar 14;32(11):1408-15. doi: 10.1038/onc.2012.161. Epub 2012 May 14.

18.

Acute activation of β2-adrenergic receptor regulates focal adhesions through βArrestin2- and p115RhoGEF protein-mediated activation of RhoA.

Ma X, Zhao Y, Daaka Y, Nie Z.

J Biol Chem. 2012 Jun 1;287(23):18925-36. doi: 10.1074/jbc.M112.352260. Epub 2012 Apr 12.

19.

Rap1GAP regulates renal cell carcinoma invasion.

Kim WJ, Gersey Z, Daaka Y.

Cancer Lett. 2012 Jul 1;320(1):65-71. doi: 10.1016/j.canlet.2012.01.022. Epub 2012 Jan 20.

20.

G-protein coupled receptor kinase 5 regulates prostate tumor growth.

Kim JI, Chakraborty P, Wang Z, Daaka Y.

J Urol. 2012 Jan;187(1):322-9. doi: 10.1016/j.juro.2011.09.049. Epub 2011 Nov 17.

PMID:
22099983
21.

PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway.

Zhang Y, Daaka Y.

Blood. 2011 Nov 10;118(19):5355-64. doi: 10.1182/blood-2011-04-350587. Epub 2011 Sep 16.

22.

Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway.

Wu J, Zhang Y, Frilot N, Kim JI, Kim WJ, Daaka Y.

J Biol Chem. 2011 Sep 30;286(39):33954-62. doi: 10.1074/jbc.M110.187344. Epub 2011 Aug 10.

23.

S-nitrosylation-regulated GPCR signaling.

Daaka Y.

Biochim Biophys Acta. 2012 Jun;1820(6):743-51. doi: 10.1016/j.bbagen.2011.03.007. Epub 2011 Mar 21.

24.

Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.

Eruslanov E, Daurkin I, Vieweg J, Daaka Y, Kusmartsev S.

Int Immunopharmacol. 2011 Jul;11(7):848-55. doi: 10.1016/j.intimp.2011.01.033. Epub 2011 Feb 11.

25.

Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli.

Wang Z, Humphrey C, Frilot N, Wang G, Nie Z, Moniri NH, Daaka Y.

J Cell Biol. 2011 Jan 10;192(1):101-10. doi: 10.1083/jcb.201003027.

26.

Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome.

Kim JI, Lakshmikanthan V, Frilot N, Daaka Y.

Mol Cancer Res. 2010 Apr;8(4):569-77. doi: 10.1158/1541-7786.MCR-09-0511. Epub 2010 Mar 30.

27.

Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer.

Lakshmikanthan V, Zou L, Kim JI, Michal A, Nie Z, Messias NC, Benovic JL, Daaka Y.

Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9379-84. doi: 10.1073/pnas.0900258106. Epub 2009 May 20.

28.

Arf GTPase-activating protein AGAP2 regulates focal adhesion kinase activity and focal adhesion remodeling.

Zhu Y, Wu Y, Kim JI, Wang Z, Daaka Y, Nie Z.

J Biol Chem. 2009 May 15;284(20):13489-96. doi: 10.1074/jbc.M900469200. Epub 2009 Mar 24.

29.

2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.

Shah S, Hess-Wilson JK, Webb S, Daly H, Godoy-Tundidor S, Kim J, Boldison J, Daaka Y, Knudsen KE.

Mol Cancer Res. 2008 Sep;6(9):1507-20. doi: 10.1158/1541-7786.MCR-07-2166.

30.

Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells.

Bagchi G, Wu J, French J, Kim J, Moniri NH, Daaka Y.

Cancer Res. 2008 May 1;68(9):3225-31. doi: 10.1158/0008-5472.CAN-07-5026.

31.

Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2.

Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, Koch WJ, Daaka Y, Lefkowitz RJ, Stamler JS.

Cell. 2007 May 4;129(3):511-22.

32.

Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction.

Moniri NH, Daaka Y.

Biochem Pharmacol. 2007 Jun 30;74(1):64-73. Epub 2007 Mar 24.

PMID:
17451656
33.

Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells.

Guo R, Kasbohm EA, Arora P, Sample CJ, Baban B, Sud N, Sivashanmugam P, Moniri NH, Daaka Y.

Endocrinology. 2006 Oct;147(10):4883-92. Epub 2006 Jun 29.

PMID:
16809448
34.

A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.

Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, Casey PJ.

J Biol Chem. 2006 Sep 8;281(36):26483-90. Epub 2006 Jun 20.

35.

The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis.

Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y, Dewhirst MW, Fields TA, Casey PJ.

Proc Natl Acad Sci U S A. 2006 May 23;103(21):8173-8. Epub 2006 May 16.

36.

Nitric oxide regulates endocytosis by S-nitrosylation of dynamin.

Wang G, Moniri NH, Ozawa K, Stamler JS, Daaka Y.

Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1295-300. Epub 2006 Jan 23.

37.

Androgen receptor activation by G(s) signaling in prostate cancer cells.

Kasbohm EA, Guo R, Yowell CW, Bagchi G, Kelly P, Arora P, Casey PJ, Daaka Y.

J Biol Chem. 2005 Mar 25;280(12):11583-9. Epub 2005 Jan 14.

38.

Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.

Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y.

Prostate. 2004 Oct 1;61(2):105-13.

PMID:
15305333
39.

Requirement for G proteins in insulin-like growth factor-I-induced growth of prostate cells.

Lyons-Darden T, Daaka Y.

J Mol Endocrinol. 2004 Aug;33(1):165-73.

PMID:
15291751
40.

Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.

Cisco RM, Abdel-Wahab Z, Dannull J, Nair S, Tyler DS, Gilboa E, Vieweg J, Daaka Y, Pruitt SK.

J Immunol. 2004 Jun 1;172(11):7162-8.

41.

G protein-coupled receptors provide survival signals in prostate cancer.

Yowell CW, Daaka Y.

Clin Prostate Cancer. 2002 Dec;1(3):177-81. Review.

PMID:
15046693
42.

Interleukin 6 mediates the lysophosphatidic acid-regulated cross-talk between stromal and epithelial prostate cancer cells.

Sivashanmugam P, Tang L, Daaka Y.

J Biol Chem. 2004 May 14;279(20):21154-9. Epub 2004 Mar 15.

43.

G proteins in cancer: the prostate cancer paradigm.

Daaka Y.

Sci STKE. 2004 Jan 13;2004(216):re2. Review.

PMID:
14734786
44.

Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth.

Bookout AL, Finney AE, Guo R, Peppel K, Koch WJ, Daaka Y.

J Biol Chem. 2003 Sep 26;278(39):37569-73. Epub 2003 Jul 17.

45.

Bradykinin receptor subtype 1 expression and function in prostate cancer.

Taub JS, Guo R, Leeb-Lundberg LM, Madden JF, Daaka Y.

Cancer Res. 2003 May 1;63(9):2037-41.

46.

Regulation of epidermal growth factor receptor internalization by G protein-coupled receptors.

Kim J, Ahn S, Guo R, Daaka Y.

Biochemistry. 2003 Mar 18;42(10):2887-94.

PMID:
12627954
47.

Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

Barki-Harrington L, Bookout AL, Wang G, Lamb ME, Leeb-Lundberg LM, Daaka Y.

Biochem J. 2003 Apr 15;371(Pt 2):581-7.

48.

Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.

Kue PF, Taub JS, Harrington LB, Polakiewicz RD, Ullrich A, Daaka Y.

Int J Cancer. 2002 Dec 20;102(6):572-9.

49.

Mitogenic action of LPA in prostate.

Daaka Y.

Biochim Biophys Acta. 2002 May 23;1582(1-3):265-9. Review.

PMID:
12069837
50.

Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor.

Ahn S, Kim J, Lucaveche CL, Reedy MC, Luttrell LM, Lefkowitz RJ, Daaka Y.

J Biol Chem. 2002 Jul 19;277(29):26642-51. Epub 2002 May 13.

Supplemental Content

Support Center